- Home
- EDSA vs SGLY Comparison
EDSA vs SGLY Comparison
Compare EDSA & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- SGLY
- Stock Information
- Founded
- EDSA 2015
- SGLY 2001
- Country
- EDSA Canada
- SGLY United States
- Employees
- EDSA N/A
- SGLY N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- SGLY
- Sector
- EDSA Health Care
- SGLY
- Exchange
- EDSA Nasdaq
- SGLY Nasdaq
- Market Cap
- EDSA 6.1M
- SGLY 5.8M
- IPO Year
- EDSA N/A
- SGLY 2008
- Fundamental
- Price
- EDSA $1.73
- SGLY $1.55
- Analyst Decision
- EDSA Strong Buy
- SGLY
- Analyst Count
- EDSA 1
- SGLY 0
- Target Price
- EDSA $21.00
- SGLY N/A
- AVG Volume (30 Days)
- EDSA 30.6K
- SGLY 13.4K
- Earning Date
- EDSA 02-07-2025
- SGLY 11-14-2024
- Dividend Yield
- EDSA N/A
- SGLY N/A
- EPS Growth
- EDSA N/A
- SGLY N/A
- EPS
- EDSA N/A
- SGLY N/A
- Revenue
- EDSA N/A
- SGLY $2,742,157.00
- Revenue This Year
- EDSA N/A
- SGLY N/A
- Revenue Next Year
- EDSA N/A
- SGLY N/A
- P/E Ratio
- EDSA N/A
- SGLY N/A
- Revenue Growth
- EDSA N/A
- SGLY N/A
- 52 Week Low
- EDSA $1.55
- SGLY $1.27
- 52 Week High
- EDSA $5.99
- SGLY $7.65
- Technical
- Relative Strength Index (RSI)
- EDSA 31.51
- SGLY 43.10
- Support Level
- EDSA $1.73
- SGLY $1.58
- Resistance Level
- EDSA $1.99
- SGLY $1.71
- Average True Range (ATR)
- EDSA 0.19
- SGLY 0.09
- MACD
- EDSA 0.02
- SGLY -0.00
- Stochastic Oscillator
- EDSA 18.00
- SGLY 35.71
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.